医院结算单隐藏的“秘密” 陵水医改解决“三医联动”难题

2017-09-02 任明超 潘在文 中国青年报

陵水的医疗改革获得了国务院的肯定,最近卫计委专门对陵水医改进行了调研,并在全国的会议上介绍了相关经验。

61604元,这是海南省陵水黎族自治县33岁贫困农民黄亚小住院10天的医疗总费用,8月11日出院的当天,县人民医院给了他一张结算单,他个人自付5926元,报销的比例达到了90%多。

黄亚小的重症肝炎因为这次治疗得到了根本好转,但对他来说,如果治疗费用全部自己掏,可能根本负担不了。

医院的结算单里隐藏着黄亚小受益于陵水县“三医联动”改革的秘密:整合城镇居民医保和新农合时采用“七统一”,整合补偿政策时“待遇就高不就低、‘三大目录’就宽不就窄”,患者看病报销不仅少跑了部门、少走了环节,而且得到更多实惠。

2016年2月,海南省在陵水县率先启动“三医联动”试点。

以前,群众看病报销要重复提交各种材料,报销周期少则4个月,多则半年。陵水县用“一站式报销平台”解决了这一难题。

“一站式报销平台”于2017年5月26日在陵水县人民医院上线运行,它汇集了县社保局、民政局、卫计委、县医院、人保等单位的信息,即使报销内容除基本医疗保险外,还包括城乡居民大病保险、城乡居民补充医疗保险、民政医疗救助、慈善会重大疾病医疗救助等,“一站式报销平台”也可以仅用1天就搞定。

方便群众的背后是政府的强力整合。陵水县在把城镇居民医保和新农合整合为城乡居民医保的过程中,实施了“七统一”,即统一经办机构、统一参保登记、统一基金统筹、同一基金管理与分配、统一保障政策待遇、统一结算支付管理、统一信息系统。这些“统一”,麻烦的是政府,方便的是群众。

据介绍,2016年,陵水县参保人数31.94万人,人均筹资540元,共筹资1.73亿元,补偿支出1.48亿元,补偿水平得到提高。基金使用率85.55%,医保基金运行安全平稳。

陵水医改用一年多的时间实现了“一升两降一涨”的明显效果,即乡镇、社区首诊率上升至70%以上,住院病人县域外转诊人数下降、药品价格下降,医务人员工资上升。

作为陵水县医改的重要经办人、陵水县卫计委胡鹏鹏见证了“三医联动”的全程。胡鹏鹏介绍,陵水县医改前后,以政府名义密集出台了20多个重要文件,在资金分配、制度建设、人才引进等方面向医改倾斜。今年3月,该县完成安置全县医疗卫生机构编外人员595人,人员工资全部纳入财政预算,让编外聘用人员吃下“定心丸”,仅此一项,县财政每年就要增加安置费用2542.14万。

陵水县卫计委的统计显示了医改的成效:该县三家公立医院总诊疗人次由45.15万人次增长到55.36万人次,增长率22.61%;县医院职工年平均工资达到8.45万元/人,比2015年提高13.89%,明显高于全县平均工资水平;全县公立医院药占比从40.07%持续下降至36.98%;全县三家公立医院门诊费用持续下降;2016年7-12月城乡医保合并后,城乡居民医疗保险住院实际补偿比达61.45%,同比提升2.14个百分点。

陵水的医疗改革获得了国务院的肯定,最近卫计委专门对陵水医改进行了调研,并在全国的会议上介绍了相关经验。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1723161, encodeId=64bf1e231617b, content=<a href='/topic/show?id=bb901959284' target=_blank style='color:#2F92EE;'>#三医联动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19592, encryptionId=bb901959284, topicName=三医联动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=173833370724, createdName=lizhou0215, createdTime=Sat Dec 16 08:34:00 CST 2017, time=2017-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670231, encodeId=c87316e0231a1, content=<a href='/topic/show?id=c50be87281c' target=_blank style='color:#2F92EE;'>#结算#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78728, encryptionId=c50be87281c, topicName=结算)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=178c26602075, createdName=vividelife, createdTime=Sat Sep 09 14:34:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286805, encodeId=e5c512868050d, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sun Sep 03 22:34:00 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239895, encodeId=b34623989531, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sun Sep 03 06:41:02 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239665, encodeId=d7122396652c, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Sat Sep 02 09:29:51 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239615, encodeId=71c12396159b, content=文章很好.值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sat Sep 02 07:46:18 CST 2017, time=2017-09-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1723161, encodeId=64bf1e231617b, content=<a href='/topic/show?id=bb901959284' target=_blank style='color:#2F92EE;'>#三医联动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19592, encryptionId=bb901959284, topicName=三医联动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=173833370724, createdName=lizhou0215, createdTime=Sat Dec 16 08:34:00 CST 2017, time=2017-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670231, encodeId=c87316e0231a1, content=<a href='/topic/show?id=c50be87281c' target=_blank style='color:#2F92EE;'>#结算#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78728, encryptionId=c50be87281c, topicName=结算)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=178c26602075, createdName=vividelife, createdTime=Sat Sep 09 14:34:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286805, encodeId=e5c512868050d, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sun Sep 03 22:34:00 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239895, encodeId=b34623989531, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sun Sep 03 06:41:02 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239665, encodeId=d7122396652c, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Sat Sep 02 09:29:51 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239615, encodeId=71c12396159b, content=文章很好.值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sat Sep 02 07:46:18 CST 2017, time=2017-09-02, status=1, ipAttribution=)]
    2017-09-09 vividelife
  3. [GetPortalCommentsPageByObjectIdResponse(id=1723161, encodeId=64bf1e231617b, content=<a href='/topic/show?id=bb901959284' target=_blank style='color:#2F92EE;'>#三医联动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19592, encryptionId=bb901959284, topicName=三医联动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=173833370724, createdName=lizhou0215, createdTime=Sat Dec 16 08:34:00 CST 2017, time=2017-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670231, encodeId=c87316e0231a1, content=<a href='/topic/show?id=c50be87281c' target=_blank style='color:#2F92EE;'>#结算#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78728, encryptionId=c50be87281c, topicName=结算)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=178c26602075, createdName=vividelife, createdTime=Sat Sep 09 14:34:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286805, encodeId=e5c512868050d, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sun Sep 03 22:34:00 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239895, encodeId=b34623989531, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sun Sep 03 06:41:02 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239665, encodeId=d7122396652c, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Sat Sep 02 09:29:51 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239615, encodeId=71c12396159b, content=文章很好.值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sat Sep 02 07:46:18 CST 2017, time=2017-09-02, status=1, ipAttribution=)]
    2017-09-03 tidiq
  4. [GetPortalCommentsPageByObjectIdResponse(id=1723161, encodeId=64bf1e231617b, content=<a href='/topic/show?id=bb901959284' target=_blank style='color:#2F92EE;'>#三医联动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19592, encryptionId=bb901959284, topicName=三医联动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=173833370724, createdName=lizhou0215, createdTime=Sat Dec 16 08:34:00 CST 2017, time=2017-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670231, encodeId=c87316e0231a1, content=<a href='/topic/show?id=c50be87281c' target=_blank style='color:#2F92EE;'>#结算#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78728, encryptionId=c50be87281c, topicName=结算)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=178c26602075, createdName=vividelife, createdTime=Sat Sep 09 14:34:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286805, encodeId=e5c512868050d, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sun Sep 03 22:34:00 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239895, encodeId=b34623989531, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sun Sep 03 06:41:02 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239665, encodeId=d7122396652c, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Sat Sep 02 09:29:51 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239615, encodeId=71c12396159b, content=文章很好.值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sat Sep 02 07:46:18 CST 2017, time=2017-09-02, status=1, ipAttribution=)]
    2017-09-03 131****1460

    学习了受益匪浅

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1723161, encodeId=64bf1e231617b, content=<a href='/topic/show?id=bb901959284' target=_blank style='color:#2F92EE;'>#三医联动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19592, encryptionId=bb901959284, topicName=三医联动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=173833370724, createdName=lizhou0215, createdTime=Sat Dec 16 08:34:00 CST 2017, time=2017-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670231, encodeId=c87316e0231a1, content=<a href='/topic/show?id=c50be87281c' target=_blank style='color:#2F92EE;'>#结算#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78728, encryptionId=c50be87281c, topicName=结算)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=178c26602075, createdName=vividelife, createdTime=Sat Sep 09 14:34:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286805, encodeId=e5c512868050d, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sun Sep 03 22:34:00 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239895, encodeId=b34623989531, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sun Sep 03 06:41:02 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239665, encodeId=d7122396652c, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Sat Sep 02 09:29:51 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239615, encodeId=71c12396159b, content=文章很好.值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sat Sep 02 07:46:18 CST 2017, time=2017-09-02, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1723161, encodeId=64bf1e231617b, content=<a href='/topic/show?id=bb901959284' target=_blank style='color:#2F92EE;'>#三医联动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19592, encryptionId=bb901959284, topicName=三医联动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=173833370724, createdName=lizhou0215, createdTime=Sat Dec 16 08:34:00 CST 2017, time=2017-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670231, encodeId=c87316e0231a1, content=<a href='/topic/show?id=c50be87281c' target=_blank style='color:#2F92EE;'>#结算#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78728, encryptionId=c50be87281c, topicName=结算)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=178c26602075, createdName=vividelife, createdTime=Sat Sep 09 14:34:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286805, encodeId=e5c512868050d, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sun Sep 03 22:34:00 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239895, encodeId=b34623989531, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sun Sep 03 06:41:02 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239665, encodeId=d7122396652c, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Sat Sep 02 09:29:51 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239615, encodeId=71c12396159b, content=文章很好.值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sat Sep 02 07:46:18 CST 2017, time=2017-09-02, status=1, ipAttribution=)]
    2017-09-02 1e10c84am36(暂无匿称)

    文章很好.值得分享

    0

相关资讯

“三医联动”抓手在哪里?试点设立医保基金管理中心!

11月10日,国家卫生计生委举行例行新闻发布会,介绍《关于进一步推广深化医药卫生体制改革经验的若干意见》及各地医改进展情况。国家卫生计生委体改司副司长姚建红表示,从前期改革实践看,“三医”联动得好,改革就有实效,“三医”联而不动、动而不联,改革就缺乏有效抓手。医疗、医保、医药领域联动改革、形成合力是当前和今后一段时期务必突破的重点难点。姚建红说,在《意见》力推的24条医改经验当中,特别提出可开展设

医改四万亿,钱都去哪儿了?

导语: 2016年3月7日,北京大学国家发展研究院中国经济研究中心教授、博士生导师李玲在“拥抱变化——新政策下移动医疗如何发展”媒体见面会上发表即席演讲。 为什么我们中国要搞医改? 就是我们在八十年代中叶。中国大概分几块,49年建国的时候医疗是福利事业,所以那时候全国都建了人民医院,就是公立医院,最开始都没有,都是在50、60年代吃不饱饭的时候全国建了中医院、妇幼保健院等等,都是

人社部发文,部署三医联动

7月5日人社部印发《关于积极推动医疗、医保、医药联动改革的指导意见》(下称《意见》),部署医疗、医保、医药三医联动改革工作。 在今年3月份李克强总理的政府工作报告中国,在部署2016年重点工作时提出了协调推进医疗、医保、医药联动改革。对于医保改革的重点,李总理也强调,今年要实现大病保险全覆盖,以及改革医保支付方式,加快推进基本医保全国联网和异地就医结算。 如今,人社部也终于

“三医联动”——国务院释放医改大动作信号

今年我国医改将继续向纵深推进,难度系数亦是不断增加,为了给医改“清障”,国务院再次祭出政策组合拳。昨日,国务院常务会议中提出,要结合医疗、医保、医药,实现“三医”联动改革,加快临床急需药物和医疗器械产品审评审批,另外,还将支持医药企业兼并重组。在不少业内人士看来,年初旋即推出多项扶植政策,信号意义明显,医改以及促医药行业发展很可能有“大动作”。事实上,不久前国家卫计委发布的2016年卫生计生工作九

湖南提出推动三医联动改革 推行按病种、按人头等多种付费方式

日前,湖南省政府办公厅出台了关于促进医药产业健康发展的实施意见,提出推动“医疗、医保、医药”联动改革,推行按病种、按人头等多种付费方式改革,对城乡贫困人口实行政策倾斜。

减税!重典治乱!三医联动!总理报告这样谈医药

今天上午,十二届全国人大五次会议召开,国务院总理李克强的政府工作报告也是医药界关注重点。